Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Exchange Rate Effect came in at -$1000.0 in Q1 2026, down 102.63% year-on-year from $38000.0 in Q1 2025, and down 100.79% quarter-over-quarter from $127000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 102.63% year-over-year to -$1000.0 in Q1 2026; TTM through Mar 2026 was $673000.0, a 209.25% increase from a year earlier, with the FY2026 full-year figure at $673000.0, up 209.25% from the prior year.
- Exchange Rate Effect fell to -$1000.0 in Q1 2026 per SNOA's latest filing, from $127000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $410000.0 in Q2 2025 and bottomed at -$283000.0 in Q3 2024.
- The 5-year median for Exchange Rate Effect is $38000.0 (2025), against an average of $31470.6.
- Across the five-year window, Exchange Rate Effect tumbled 528.89% in 2024 and jumped 258.91% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$85000.0 in 2022, then soared by 165.88% to $56000.0 in 2023, then plunged by 301.79% to -$113000.0 in 2024, then soared by 212.39% to $127000.0 in 2025, then tumbled by 100.79% to -$1000.0 in 2026.
- Per Business Quant, the three latest SNOA Exchange Rate Effect figures stand at -$1000.0 (Q1 2026), $127000.0 (Q4 2025), and $137000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | -113,000.00 |
| Dec 31, 2024 | -113,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Jun 30, 2024 | -258,000.00 |
| Jun 30, 2024 | -258,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Dec 31, 2023 | 56,000.00 |